Treatment of Alzheimer’s Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions

In this issue, an article by La et al. provides evidence that trazodone delayed cognitive decline in 25 participants with Alzheimer’s disease (AD), mild cognitive impairment, or normal cognition. For participants considered to have AD pathology, trazodone non-users declined at a rate 2.4 times great...

Descripción completa

Detalles Bibliográficos
Autor principal: Ashford, John Wesson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398534/
https://www.ncbi.nlm.nih.gov/pubmed/30776014
http://dx.doi.org/10.3233/JAD-181106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398534/
https://www.ncbi.nlm.nih.gov/pubmed/30776014
http://dx.doi.org/10.3233/JAD-181106

Ejemplares similares